Company / Operating Income per Share
IRONWOOD PHARMACEUTICALS INC Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.61
FY2025
5-year range
-$6.14 / $1.60
FY2021-FY2025
Trend
-61.6%
vs FY2024
Sector context
#44 of 201
Health Care
What the data says
IRONWOOD PHARMACEUTICALS INC's operating income per share of $0.61 is higher than 78% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 10 years, ranging from $-6.14 in FY2023 to $1.60 in FY2024.
Based on SEC 10-K filings.
0.61 in FY2025 with a 3-year CAGR of -11.3%. Top quartile in the Health Care sector.
Improved from $-6.14 to $0.61 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -11.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
+119.0% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 61.6% year-over-year.
- Ranks #44 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2024.
- Lowest operating income per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.61 | -61.6% |
| FY2024 | $1.60 | +126.1% |
| FY2023 | -$6.14 | -795.8% |
| FY2022 | $0.88 | -39.0% |
| FY2021 | $1.45 | +251.2% |
| FY2020 | -$0.96 | -222.9% |
| FY2019 | $0.78 | +317.4% |
| FY2018 | -$0.36 | -231.2% |
| FY2017 | -$0.11 | +71.5% |
| FY2016 | -$0.38 | +57.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026